Related Experiment Video
Updated: Jul 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Genetic predisposition in sarcomas: clinical implications and management.
Elizabeth A Connolly1,2, Kjetil Boye3, Sylvie Bonvalot4
1Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
Genetic predisposition may influence sarcoma treatment, but evidence is scarce. This review offers pragmatic advice for managing patients with genetic predisposition syndromes and highlights the need for further research.
Area of Science:
- Oncology
- Genetics
- Medical Management
Background:
- Sarcomas are increasingly linked to genetic predisposition genes, with up to 20% potentially affected.
- Limited evidence exists for managing sarcoma patients with known genetic predispositions.
Purpose of the Study:
- To review current research on genetic predisposition syndromes associated with sarcoma.
- To address knowledge gaps in sarcoma treatment for patients with genetic predispositions.
- To explore how genetic factors influence treatment decisions and clinical management.
Main Methods:
- Comprehensive literature review of genetic predisposition syndromes and sarcoma.
- Analysis of existing evidence on surgical, radiotherapeutic, and systemic treatment approaches.
- Focus on surveillance strategies for affected individuals.
Main Results:
- Evidence-based recommendations for sarcoma management in genetic predisposition syndromes are largely unavailable.
- Pragmatic clinical advice is provided due to the scarcity of formal guidelines.
- Key knowledge gaps and unmet needs in this field are identified.
Conclusions:
- Multidisciplinary input from geneticists, radiologists, surgeons, and oncologists is crucial.
- Future research is essential to enhance clinical outcomes for sarcoma patients with genetic predispositions.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention
Some...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

